SCHEMBL6067938

SCHEMBL6067938

Oc1cccc(O)c1-c1ccc(Cl)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 5/20 0.50
HSD17B2 P37059 4/20 0.50
CYP2A6 P11509 1/20 0.41
MAOA P21397 2/20 0.40
AURKA O14965 1/20 0.39
AURKB Q96GD4 1/20 0.39
TSHR P16473 3/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
MAOB P27338 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
F2 P00734 1/20 0.39
PLAU P00749 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5712450 0.91 HSD17B1 (0.44) HSD17B1HSD17B2CYP2A6MAOAAURKA
SCHEMBL23795185 0.77 HSD17B1 (0.44) HSD17B1HSD17B2CYP2A6ALDH1A1LMNA
SCHEMBL6067814 0.76 CYP3A4 (0.42) HSD17B1HSD17B2CYP2A6MAOAAURKA
SCHEMBL6067804 0.74 ALDH1A1 (0.42) HSD17B1HSD17B2MAOATSHRALDH1A1
SCHEMBL9193008 0.72 CYP2A6 (0.50) HSD17B1HSD17B2CYP2A6TSHRALDH1A1
SCHEMBL4454574 0.71 APP (0.70) HSD17B1HSD17B2CYP2A6IKBKB
SCHEMBL30393125 0.70 CYP2A6 (0.48) HSD17B1HSD17B2CYP2A6TSHRALDH1A1
SCHEMBL5673936 0.69 HSD17B1 (0.93) HSD17B1HSD17B2
SCHEMBL5712508 0.69 ALOX15 (0.41) HSD17B1HSD17B2CYP2A6MAOATSHR
SCHEMBL5704914 0.68 CA1 (0.44) HSD17B1HSD17B2TSHRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100349886-C 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2007-11-21 CN disclosed
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US disclosed
CN-1633426-A 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2005-06-29 CN disclosed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds KRT18, DSP, COL1A1 HSD17B1 746/4885HSD17B2 1218/4885CYP2A6 772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.